Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|October 11, 2011
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescuePatrizia Chiusolo, Sabrina Giammarco, Silvia Bellesi, et al.
Frontiers in Immunology|May 21, 2021
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021Andrea Bacigalupo, Idanna Innocenti, Elena Rossi, et al.
European Journal of Haematology|July 26, 2023
Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T-cells (CAR-T): A comprehensive review on incidence, risk factors and current managementEugenio Galli, Alberto Fresa, Silvia Bellesi, et al.
Transfusion Medicine Reviews|June 14, 2023
Peripheral Blood Allogeneic Stem Cell Mobilization: Can We Predict a Suboptimal Mobilization?Nicola Piccirillo, Rossana Putzulu, Elisabetta Metafuni, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 13, 2024
Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages eraAlessandra Vergori, Alessandro Cozzi Lepri, Marta Chiuchiarelli, et al.
Haematologica|May 28, 2026
Unrelated cord blood transplantation and post-transplant cyclophosphamidePatrizia Chiusolo, Andrea Bacigalupo, Sabrina Giammarco, et al.
British Journal of Haematology|December 12, 2022
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T cellsEugenio Galli, Federica Sorà, Stefan Hohaus, et al.
Frontiers in Oncology|September 19, 2022
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patientsPatrizia Chiusolo, Elisabetta Metafuni, Gessica Minnella, et al.
International Journal of Molecular Sciences|June 12, 2026
TP53 Mutations Unfavorably Impact the Outcomes of Myelofibrosis Patients with or Without Hematopoietic Stem Cell Transplantation: A Single-Center Study and Meta-AnalysisFilippo Frioni, Sabrina Giammarco, Sara Ceglie, et al.
Frontiers in Oncology|July 17, 2024
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature reviewElisabetta Metafuni, Maria Teresa Busnego Barreto, Caterina Giovanna Valentini, et al.
Pageof 7